A Win For Matinas BioPharma Holdings, Inc.
Wed, Oct 11, 2023 at 07:25 PM
Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT) rocketted at $0.64, representing a gain of 313.5%. On Wed, Oct 11, 2023, MTNB:NYSEMKT hit a New 2-Week High of $0.64. The stock appeared on our News Catalysts scanner on Wed, Oct 11, 2023 at 10:53 AM in the 'BIOTECH' category. From Wed, Sep 27, 2023, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Wed, Oct 11, 2023 at $0.89 with a volume of 349M+.
About Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT)
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company engaged in identifying & developing safe and effective broad spectrum therapeutics for the treatment of serious and life-threatening infections.
Top 10 Gainers:
- Tempest Therapeutics Inc. (TPST:NASDAQ), 2879.17%
- Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT), 313.55%
- Phio Pharmaceuticals Corp. (PHIO:NASDAQ), 91.18%
- Tupperware Brands Corporation (TUP:NYSE), 55.33%
- Athena Consumer Acquisition Corp. Class A (ACAQ:NYSEMKT), 54.44%
- Athena Consumer Acquisition Corp. Class A (ACAQ:NYSE), 54.44%
- Asset Entities Inc. (ASST:NASDAQ), 45%
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 41.3%
- Bird Global Inc. Class A (BRDS:NYSE), 34.44%
- voxeljet AG (VJET:NASDAQ), 33.98%